As both peripheral inflammation and vascular diseases are shown to increase AD risk, two cross-sectional studies showed that AD patients had a lower number of circulating CD34+CD133+ cells [13] or CD34+ cells [14] than controls. This evidence concerns the gene PROM1 and Alzheimer disease.